Les Meilleurs doctors pour le traitement de cancer de l'intestin grêle en Israël - TOP-20 des médecins

Le Dr Pelles Sharon se spécialise dans les traitements avancés du cancer, y compris le cancer de l'intestin grêle, au centre médical Sourasky (Ichilov).

• Proposer une gamme de traitements chirurgicaux et non chirurgicaux tels que la thérapie SIRT et le HIPEC
• Être actif dans la recherche clinique, contribuant à des études sur les attitudes des patients oncologiques
• Fournir des options d'immunothérapie et de thérapie ciblée
• Être qualifié dans les chirurgies du cancer du foie et du pancréas

Le Pr Merimsky dirige l'unité d'oncologie des tissus mous et des os au centre médical Sourasky, se spécialisant dans les tumeurs rares comme le cancer de l'intestin grêle.

• Plus de 25 ans d'expérience en oncologie, axée sur les sarcomes et les cancers rares
• Chercheur principal à l'Institut Weizmann et à l'Université de Tel-Aviv
• Membre de la faculté des sarcomes de l'ESMO et du comité d'éthique de l'IASLC
• Formation à l'Institut Gustave Roussy, Paris – le premier centre européen de lutte contre le sarcome

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Le Dr Wolf dirige la division d'oncologie médicale du centre médical Sourasky, l'un des hôpitaux les plus importants et les plus renommés d'Israël.

• Diriger la division qui traite les cancers gastro-intestinaux complexes
• Détenir des diplômes et une formation approfondie en oncologie médicale
• Être expérimenté dans la gestion de cas de cancer rares comme ceux de l'intestin grêle
• Travailler au sein d'un centre médical universitaire majeur pour des protocoles de traitement avancés

Le Dr Greenberg est un expert de premier plan en chirurgie de Whipple – une intervention clé pour le cancer de l'intestin grêle – et dirige le département de chirurgie colorectale du centre médical Sourasky.

• Plus de 20 ans d'expérience en tant que chirurgien abdominal
• Pratiquer des techniques chirurgicales ouvertes et mini-invasives
• Diriger un département spécialisé dans un grand hôpital de soins tertiaires

Directeur de l'hospitalisation oncologique au centre médical de Tel Aviv – Le Dr Stepfansky dirige une unité d'oncologie spécialisée dans le cancer de l'intestin grêle.

• Plus de 25 ans d'expérience en oncologie et en médecine interne
• Chercheur principal et secondaire dans des essais cliniques de phases 1 à 3
• Formé au centre médical de Tel Aviv, l'un des principaux hôpitaux d'Israël
• Spécialiser dans le diagnostic et le traitement du cancer de l'intestin grêle

Le Dr Klauzner est reconnu comme l'un des meilleurs chirurgiens d'Israël pour l'intervention de Whipple – une procédure complexe pour les tumeurs de l'appareil digestif. Il dirige le département de chirurgie du centre médical Sourasky (Ichilov).

• Se spécialiser dans les chirurgies des cancers gastro-intestinaux, du pancréas et colorectal
• Plus de 45 ans d'expérience chirurgicale
• Occuper le poste de président du département de chirurgie

33 ans de spécialisation en oncologie et radiothérapie – Le Dr Auala Hubert dirige le centre des cancers gastro-intestinaux au Hadassah Medical Center.

• Certifié en oncologie et radiothérapie
• Diplômé de l'hôpital universitaire Hadassah
• Parle couramment l'anglais et l'hébreu
• Membre de plusieurs associations d'oncologie

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Directeur adjoint du département d'oncologie au centre médical Rambam – un rôle de premier plan dans les soins contre le cancer.

• Se spécialiser dans le traitement du cancer de l'intestin grêle
• Travailler dans un centre médical de premier plan en Israël
• Occuper un poste de direction en oncologie

Spécialiste en chirurgie endoscopique – Le Dr Kashtan se concentre sur les techniques mini-invasives pour le cancer de l'intestin grêle au centre médical Assuta.

• Formé aux procédures endoscopiques avancées
• Travaille dans l'un des principaux centres d'oncologie d'Israël
• Expertise dans le traitement du cancer de l'intestin grêle

Le Dr Gutman est un oncochirurgien spécialisé dans le cancer de l'intestin grêle au centre médical Assuta.

• Se spécialiser en oncologie chirurgicale avec une expertise dans les cas d'intestin grêle
• Travailler au centre médical Assuta – un hôpital oncologique de premier plan
• Fournir des plans de traitement personnalisés pour chaque patient

Le Dr Alexander Beny est directeur du service des tumeurs malignes gastro-intestinales au centre médical Rambam, spécialisé dans le cancer de l'intestin grêle.

• Oncologue certifié, titulaire de l'examen du Conseil de la Communauté Européenne en médecine
• Diriger la clinique d'oncologie gastro-intestinale au centre médical Rambam
• Formé aux techniques modernes de curiethérapie via le cours de l'ESTRO
• Expérimenté dans les approches d'oncologie médicale et de radiothérapie